Red blood cells and their releasates compromise bone marrow-derived human mesenchymal stem/stromal cell survival in vitro.

Apoptosis Bone marrow aspirate concentrate Hematocrit Mesenchymal stem cells Necrosis Red blood cells Viability

Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
21 10 2021
Historique:
received: 19 05 2021
accepted: 18 08 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 30 10 2021
Statut: epublish

Résumé

The use of bone marrow aspirate (BMA) and bone marrow aspirate concentrate (BMC) in the treatment of inflammatory orthopedic conditions has become a common practice. The therapeutic effect of BMA/BMC is thought to revolve primarily around the mesenchymal stem/stromal cell (MSC) population residing within the nucleated cell fraction. MSCs have the unique ability to respond to site of injury via the secretion of immunomodulating factors, resolving inflammation in diseased joints. Recently, the importance of hematocrit (HCT) in BMC has been debated, as the potential impact on MSC function is unknown. In the present study, we investigate MSC health over a short time-course following exposure to a range of HCT and red blood cell releasate (RBC Bone marrow-derived human MSCs in early passage were grown under conditions of 0%, 2.5%, 5%, 10%, 20% and 40% HCT and RBC Significant reductions in viable MSCs concurrent with an increase in necrotic MSCs in high HCT and RBC Various levels of HCT and RBC

Identifiants

pubmed: 34674751
doi: 10.1186/s13287-021-02610-4
pii: 10.1186/s13287-021-02610-4
pmc: PMC8529765
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

547

Informations de copyright

© 2021. The Author(s).

Références

J Clin Biochem Nutr. 2017 Jan;60(1):39-48
pubmed: 28163381
Stem Cells Int. 2017;2017:2638305
pubmed: 28698718
Chin J Cancer Res. 2011 Mar;23(1):43-8
pubmed: 23467386
Cell Stem Cell. 2015 Mar 5;16(3):239-53
pubmed: 25748931
Stem Cells Transl Med. 2017 Jun;6(6):1445-1451
pubmed: 28452204
Spine J. 2020 Nov;20(11):1850-1860
pubmed: 32565315
Scand J Immunol. 2004 Jun;59(6):559-65
pubmed: 15182251
Orthop J Sports Med. 2019 Mar 29;7(3):2325967119835197
pubmed: 30968049
Trends Cell Biol. 2016 Mar;26(3):165-176
pubmed: 26653790
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Orthop J Sports Med. 2019 Mar 29;7(3):2325967119835187
pubmed: 30969283
Sci Rep. 2018 Feb 15;8(1):3101
pubmed: 29449599
Front Pharmacol. 2018 Nov 06;9:1267
pubmed: 30459621
J Exp Med. 2011 Mar 14;208(3):421-8
pubmed: 21402747
Bone. 2004 Apr;34(4):665-71
pubmed: 15050897
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
Avicenna J Med Biotechnol. 2013 Apr;5(2):104-17
pubmed: 23799179
Methods Mol Biol. 2013;1035:75-101
pubmed: 23959984
Cartilage. 2019 Oct;10(4):387-394
pubmed: 29652173
Cell Stem Cell. 2014 Aug 7;15(2):154-68
pubmed: 24953181
Cytotherapy. 2013 Feb;15(2):242-52
pubmed: 23245952
Cell Mol Immunol. 2017 Feb;14(2):146-179
pubmed: 27721455
J Equine Vet Sci. 2020 Mar;86:102820
pubmed: 32067662
J Orthop Res. 2014 Feb;32(2):291-5
pubmed: 24122902
J Clin Med. 2019 Dec 18;9(1):
pubmed: 31861268
Libyan J Med. 2007 Dec 01;2(4):190-201
pubmed: 21503244
World J Stem Cells. 2016 Mar 26;8(3):73-87
pubmed: 27022438
Stroke. 2019 Oct;50(10):2883-2891
pubmed: 31510901
Regen Ther. 2019 May 10;11:56-64
pubmed: 31193111
Stem Cells Int. 2019 Aug 1;2019:5197983
pubmed: 31467563
Am J Sports Med. 2014 Mar;42(3):610-8
pubmed: 24481828
Am J Pathol. 2003 Mar;162(3):943-51
pubmed: 12598327
J Transl Med. 2019 Jan 5;17(1):10
pubmed: 30611285
Cell Death Differ. 2010 Jun;17(6):922-30
pubmed: 20010783
Am J Sports Med. 2014 May;42(5):1204-10
pubmed: 24634448
J Am Coll Cardiol. 2010 Mar 30;55(13):1385-94
pubmed: 20338501
Cell Death Discov. 2019 Feb 8;5:65
pubmed: 30774993
Cell Death Dis. 2020 Feb 3;11(2):88
pubmed: 32015325
Am J Sports Med. 2016 Mar;44(3):792-800
pubmed: 25925602
Exp Mol Med. 2020 Jan;52(1):1-6
pubmed: 31915368
J Cutan Aesthet Surg. 2014 Oct-Dec;7(4):189-97
pubmed: 25722595
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970

Auteurs

Ryan Christopher Dregalla (RC)

4795 Larimer Parkway, Elite Regenerative Stem Cell Specialists, LLC, Johnstown, CO, 80534, USA. rdregalla@DreMedTech.com.
R&D Regenerative Laboratory Resources, LLC, 4795 Larimer Parkway, Johnstown, CO, 80534, USA. rdregalla@DreMedTech.com.

Jessica Ann Herrera (JA)

4795 Larimer Parkway, Elite Regenerative Stem Cell Specialists, LLC, Johnstown, CO, 80534, USA.
R&D Regenerative Laboratory Resources, LLC, 4795 Larimer Parkway, Johnstown, CO, 80534, USA.

Edward Jeffery Donner (EJ)

4795 Larimer Parkway, Elite Regenerative Stem Cell Specialists, LLC, Johnstown, CO, 80534, USA.
R&D Regenerative Laboratory Resources, LLC, 4795 Larimer Parkway, Johnstown, CO, 80534, USA.
4795 Larimer Parkway, Colorado Spine Institute, PLLC, Johnstown, CO, 80534, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH